Clinical Trials on Glabellar Crease in India
Total 204 results
-
MediGeneCompletedBreast NeoplasmsBelgium, France, Poland, India, Romania, Ukraine
-
GlaxoSmithKlineCompletedNeoplasms, BreastTaiwan, Peru, United States, Hong Kong, Chile, India, Mexico, Poland, Pakistan, Singapore, Malaysia
-
PfizerTerminatedAdvanced Breast CancerUnited States, Hungary, Spain, Belgium, China, Hong Kong, Australia, Poland, Canada, India, South Africa
-
Novartis PharmaceuticalsCompleted
-
PfizerCompletedBreast NeoplasmsBelgium, Brazil, United States, India, Peru, Philippines, Mexico, Canada, Colombia
-
OBI Pharma, IncCompletedMetastatic Breast CancerUnited States, Taiwan, Korea, Republic of, China, India
-
AstraZenecaCompletedBreast CancerUnited States, Brazil, United Kingdom, Germany, Austria, India
-
AstraZenecaCompletedHER2-negativeIndia, Thailand, Brazil, Vietnam, Mexico, Hong Kong, Argentina, Indonesia, Singapore, Philippines, Panama, Dominican Republic, Malaysia
-
Baxter Healthcare CorporationCompletedMultiple Myeloma | Ovarian Cancer | Metastatic Breast Cancer | AIDS-related Kaposi SarcomaIndia
-
Puma Biotechnology, Inc.CompletedNeoplasms | Breast NeoplasmsUnited States, Belgium, India, China, Russian Federation, Mexico, France
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Early-stage Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
Hoffmann-La RocheCompletedInflammatory Breast Cancer | Early Breast Cancer | Locally Advanced Breast CancerCanada, Spain, Croatia, Bosnia and Herzegovina, Costa Rica, Singapore, Bulgaria, South Africa, Kenya, Brazil, India, Chile, Peru, Argentina, South Korea, Turkey (Türkiye), Mexico
-
Novartis PharmaceuticalsCompletedPost Menopausal Breast CancerTaiwan, Malaysia, Turkey, Australia, Korea, Republic of, Thailand, Jordan, India, Vietnam, Morocco, Tunisia, Indonesia, South Africa
-
Novartis PharmaceuticalsCompletedBreast CancerIndia, Malaysia, Saudi Arabia, Taiwan, Russian Federation, Lebanon, South Africa, Thailand, Jordan, Turkey, Egypt, Vietnam, Singapore
-
AstraZenecaCompletedBreast CancerThailand, Korea, Republic of, Japan, Philippines, Taiwan, India
-
EirGenix, Inc.CompletedBreast CancerTaiwan, India, Georgia, United States, Russian Federation, South Africa, Ukraine, Belarus, Chile, Colombia, Korea, Republic of
-
BayerCompletedBreast CancerSpain, Canada, Taiwan, United States, India, Netherlands, Poland, Germany, Argentina
-
Bristol-Myers SquibbCompletedBreast CancerUnited States, India, Korea, Republic of, Taiwan, Spain, Germany, Austria, Italy, Peru, Russian Federation, Singapore, France, United Kingdom, Philippines, Argentina
-
Eli Lilly and CompanyActive, not recruitingBreast CancerChina, India, Brazil, South Africa
-
Tolmar Inc.Enrolling by invitationBreast CancerUnited States, India, Argentina, Puerto Rico, Brazil, Mexico
-
SandozSandoz GmbHCompletedBreast Neoplasms | Chemotherapeutic Toxicity | Chemotherapy-induced Neutropenia | Neutropenic ComplicationsRussian Federation, Brazil, India, Mexico, Romania, Ukraine
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
CelltrionNippon Kayaku Co., Ltd.CompletedHER2-positive Carcinoma of BreastItaly, South Africa, Mexico, Japan, Taiwan, Russian Federation, Philippines, Hungary, Romania, Spain, Bosnia and Herzegovina, India, Peru, Ukraine, Latvia, Argentina, Georgia, Belarus, Chile, France, Poland, Portugal
-
Hoffmann-La RocheCompletedBreast CancerChina, Hong Kong, France, Spain, Italy, Turkey, Brazil, Egypt, Poland, India, Saudi Arabia
-
Jules Bordet InstituteCompletedBreast CancerUnited States, Argentina, Sweden, Spain, Belgium, Austria, Israel, Germany, France, Italy, Poland, India, Netherlands, Brazil, Mexico, Portugal, Switzerland, Serbia, Bosnia and Herzegovina, Canada, Australia, Lebanon, Georgia, Korea,... and more
-
Hoffmann-La RocheCompletedBreast CancerFrance, Italy, Spain, Turkey, Brazil, India
-
SandozSandoz GmbHCompletedBreast Cancer | Chemotherapy-induced NeutropeniaSpain, United States, Argentina, Chile, India, Malaysia, Puerto Rico, Russian Federation
-
Tolmar Inc.Active, not recruitingBreast CancerUnited States, Canada, Puerto Rico, Brazil, India, Mexico, Argentina
-
Mylan Inc.Mylan GmbHCompletedBreast CancerSlovakia, Brazil, Chile, Georgia, Hungary, India, Latvia, Peru, Romania, Russian Federation, Serbia, South Africa, Thailand, Turkey, Ukraine
-
PfizerCompletedBreast NeoplasmsUnited States, Canada, Czech Republic, Spain, Germany, Italy, India, United Kingdom
-
AstraZenecaDaiichi Sankyo Company, LimitedActive, not recruitingMetastatic Breast CancerUnited States, Italy, India, Taiwan, France, Germany, Brazil, Poland, Spain, Australia, Canada, United Kingdom, South Korea, Russia, Turkey (Türkiye)
-
Novartis PharmaceuticalsActive, not recruitingMetastatic Breast CancerUnited States, South Africa, Taiwan, Singapore, China, Italy, Lebanon, Vietnam, Portugal, Argentina, India, Peru, Hong Kong, Poland, Turkey (Türkiye), South Korea, Brazil, Costa Rica, Spain, Greece, Mexico, Japan
-
Sopherion TherapeuticsUnknownBreast CancerCanada, Spain, United States, United Kingdom, Poland, Germany, India, Italy, Argentina, Portugal, Russian Federation
-
Hoffmann-La RocheCompletedBreast CancerUnited States, United Kingdom, France, Italy, Spain, Turkey, Brazil, India
-
AviGenicsCompletedBreast Cancer | NeutropeniaUnited States, India
-
AstraZenecaTerminatedNeoplasms | Breast Cancer | Breast NeoplasmsBrazil, Czech Republic, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, South Africa, United Kingdom, Philippines, Ukraine, Finland, Canada, Taiwan, India, Thailand, United States, Japan
-
SanofiCancer International Research Group (CIRG)CompletedBreast NeoplasmsUnited States, France, Brazil, Romania, Russian Federation, Australia, Spain, Sweden, Turkey, India, Slovakia, Taiwan, Belgium, Czech Republic, Tunisia, Uruguay, Argentina, Croatia, Austria, Egypt, Greece, Hungary, Ireland, Israel, Italy, Mexic... and more
-
Pierre Fabre MedicamentCompletedBreast CancerFrance, Poland, Ukraine, United Kingdom, Taiwan, Spain, Belgium, Belarus, Mexico, Bulgaria, India, South Africa, Brazil, Russian Federation, Argentina, Hungary, Italy, Serbia, Switzerland, Czechia, Estonia
-
AstraZenecaActive, not recruitingBreast CancerBelgium, Spain, Italy, Brazil, Czechia, United States, Chile, Slovakia, Hungary, India, Ukraine, Poland, Colombia, Malta, Mexico, Venezuela, Russia
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerFrance, Canada, Israel, Italy, Argentina, Brazil, China, Croatia, Germany, Greece, Slovakia, Turkey, Saudi Arabia, Japan, India, Spain, United States, Czechia, Romania, United Kingdom, Morocco, South Africa, Vietnam, Russian Federation
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, South Africa, Austria, Hungary, Germany, Czechia, France, Thailand, Belgium, Bulgaria, Lithuania, Jordan, Sweden, Colombia, Finland, Portugal, Canada, India, Argentina, Peru, Russia, Brazil, Costa Rica
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer | Breast Neoplasms | HER2-positive Early Breast CancerUnited States, Italy, Spain, Taiwan, Thailand, Canada, Germany, Brazil, Peru, Philippines, Poland, China, Saudi Arabia, Japan, India, Bulgaria, South Korea, Russia
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited Kingdom, United States, Peru, Israel, Poland, Russian Federation, Korea, Republic of, Thailand, Pakistan, Hungary, India, Canada, France, Mexico, Malaysia, Singapore
-
Hoffmann-La RocheCompletedBreast CancerChina, United States, South Africa, Russian Federation, Thailand, Bosnia and Herzegovina, Czech Republic, India, Poland
-
Novartis PharmaceuticalsTerminatedTriple Negative Breast NeoplasmsUnited States, Croatia, Taiwan, Australia, China, Israel, France, Slovakia, Slovenia, United Kingdom, Italy, Colombia, Switzerland, Malaysia, Hungary, South Africa, Austria, Bulgaria, India, Poland, Spain, Germany, Mexico, Peru, Norway, South... and more
-
AmgenCompletedLocally Recurrent and Metastatic Breast CancerUnited States, United Kingdom, Denmark, Poland, Belgium, Hungary, Spain, Austria, France, Australia, Netherlands, Finland, India
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerIsrael, United States, Australia, Korea, Republic of, Belgium, Argentina, Denmark, Finland, Italy, Portugal, Spain, Taiwan, Thailand, Japan, United Kingdom, Brazil, Canada, Colombia, Mexico, France, Costa Rica, Switzerland, Czechia, P... and more
-
Novartis PharmaceuticalsGlaxoSmithKlineCompletedNeoplasms, BreastUnited Kingdom, Croatia, Belgium, Argentina, Israel, Poland, Russian Federation, Spain, Korea, Republic of, Hong Kong, United States, Brazil, Bulgaria, China, Germany, Hungary, India, Italy, Japan, Ukraine, Serbia, Singapore, Portugal, Fran... and more
-
Hoffmann-La RocheCompletedBreast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Brazil, France, Slovenia, Spain, Taiwan, Japan, Italy, Argentina, India, Germany, Hungary, Russian Federation, Singapore, Ukraine, Costa Rica, Czechia, G... and more
-
Novartis PharmaceuticalsCompletedBreast CancerBelgium, Hungary, Spain, Argentina, Russian Federation, Sweden, Lebanon, Australia, Denmark, Ireland, United Kingdom, Thailand, Turkey, Peru, Brazil, Malaysia, India, United States